Literature DB >> 30593853

Biomonitoring Equivalents (BEs) for tetrabromobisphenol A.

Sean M Hays1, Christopher R Kirman2.   

Abstract

Tetrabromobisphenol A (TBBPA) is a flame retardant used in a variety of products, including epoxy and polycarbonate resins. Relevant exposure to TBBPA has been assessed by measuring TBBPA in the blood of humans. Here, we derive Biomonitoring Equivalents (BEs) for TBBPA to interpret these, and future biomonitoring results for TBBPA in humans. The available toxicity risk values (TRVs) for TBBPA were all based on toxicology studies in rats. Several studies have been conducted in which TBBPA in blood of rats were measured following controlled oral doses of TBBPA. These data provide a robust relationship from which to derive BEs. BEs of 5.6 and 13.0 μg total TBBPA/L plasma were calculated for available cancer and non-cancer TRVs, respectively. Several studies have measured TBBPA in serum, with median concentrations less than 0.1 μg/L, indicating considerable margins of safety (MOS) for TBBPA based on the currently available biomonitoring studies.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biomonitoring Equivalents; Pharmacokinetics; Risk assessment; Tetrabromobisphenol A

Mesh:

Substances:

Year:  2018        PMID: 30593853     DOI: 10.1016/j.yrtph.2018.12.014

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  1 in total

1.  An Ultrasensitive Bioluminescent Enzyme Immunoassay Based on Nanobody/Nanoluciferase Heptamer Fusion for the Detection of Tetrabromobisphenol A in Sediment.

Authors:  Zhenfeng Li; Yi Wang; Natalia Vasylieva; Debin Wan; Zihan Yin; Jiexian Dong; Bruce D Hammock
Journal:  Anal Chem       Date:  2020-07-07       Impact factor: 6.986

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.